Increase of number of shares and votes in Vicore Pharma
As previously announced, the Company’s board of directors resolved on November 13, 2019, by virtue of the authorization by the annual general meeting held on May 15, 2019, on a directed share issue of 7,800,000 new shares at a subscription price of SEK 16 per share. Through the share issue, Vicore Pharma received issue proceeds of approximately SEK 125 million before issue costs.
As of today, the total number of registered and outstanding shares and votes of Vicore Pharma amounts to 50,174,714. Furthermore, the registered share capital amounts to SEK 25,087,356.756435.
For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63, email@example.com
Hans Jeppsson, CFO, tel: +46 70 553 14 65, firstname.lastname@example.org
This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on 29 November 2019 at 08:00 CET.